Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Riboxx Pharma collaborates with CNBG to evaluate potential of Riboxxim TLR3 agonist
Riboxx Pharma collaborates with CNBG to evaluate potential of Riboxxim TLR3 agonist
Riboxx Pharma collaborates with CNBG to evaluate potential of Riboxxim TLR3 agonist
Submitted by
admin
on March 6, 2013 - 10:59am
Source:
Pharmaceutical Business Review
News Tags:
Riboxx
Riboxxim
China National Biotech Group
infectious diseases
Headline:
Riboxx Pharma collaborates with CNBG to evaluate potential of Riboxxim TLR3 agonist
Do Not Allow Advertisers to Use My Personal information